Key facts
- This page summarizes Someit Sidhu's Form 4 filing for Zura Bio Ltd (ZURA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Sep 2024, 17:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.86 to $3.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
The shares are directly held by Pegasus LLC. The Reporting Person is the sole member of Pegasus LLC and the Reporting Person may be deemed to have voting and dispositive power over the shares held by Pegasus LLC. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest therein.
Footnote F3
The shares are directly held by JATT Ventures, L.P. ("JATT"). The Reporting Person is the sole director of the sole general partner of JATT and may be deemed to have voting and dispositive power over the shares held by JATT. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest therein.